Diabetic Neuropathy Market Size

Diabetic Neuropathy Market size was valued at USD 5.91 billion in 2024 and is likely to exceed USD 16.99 billion by the end of 2037, expanding at over 8.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of diabetic neuropathy is evaluated at USD 6.31 billion.

The growth of the market can be attributed to the surge in diabetes cases globally, which is one of the major factors anticipated to drive the growth of the market during the forecast period.  For instance, according to the Centers for Disease Control and Prevention, about 1 in 10 Americans have diabetes as of 2022. Moreover, an upsurge in the prevalence of unhealthy lifestyles, such as the consumption of sugary food, a lack of exercise, smoking, and a poor sleep schedule, among others, are anticipated to boost the market growth. Moreover, diabetes will also lead to the occurrence of many other disorders, including hypertension, and heart disease. Genetics, obesity, or overweight, also play a huge role in the incidence of diabetes, and it is anticipated to boost the growth of the global market.

The increasing obesity issue across the world is one of the major factors fueling the growth of the diabetic neuropathy market during the forecast period. About 38.2 million children across the world as suffering from obesity or overweight who are less than 5 years of age according to data from the World Health Organization, 2019. Obesity is when your body gets more amount of glucose that is converted into fat, which is used for energy expenditure in the future. On the other hand, over-fat storage leads to cholesterol deposits, which are referred to as an obesity condition. Obesity also causes blockage of blood vessels and arteries, causing a heart attack. The overweight also causes a burden on the joints of the legs, as they cannot bare the excess pressure put on them, leading to an arthritis condition.